-
-
-
-
-
-
-
uniQure closes $345 million public offering with overallotment
-
-
-
-
-
-
-
uniQure Announces Pricing of its Public Offering
-
-
-
-
-
-
-
uniQure (QURE) Announces Proposed $200M Share Common Offering
-
-
-
-
-
-
-
uniQure (QURE) Granted Orphan Medicinal Product Designation in Europe for AMT-130 in Huntington’s Disease
-
-
-
-
-
-
-
Form S-3 uniQure N.V.
-
-
-
71,560 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

